Logo image of SLBEN.LS

SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) Stock Fundamental Analysis

Europe - Euronext Lisbon - ELI:SLBEN - PTSLB0AM0010 - Common Stock

6.24 EUR
-0.02 (-0.32%)
Last: 12/15/2025, 7:00:00 PM
Fundamental Rating

2

Overall SLBEN gets a fundamental rating of 2 out of 10. We evaluated SLBEN against 49 industry peers in the Entertainment industry. SLBEN has a medium profitability rating, but doesn't score so well on its financial health evaluation. SLBEN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year SLBEN has reported negative net income.
SLBEN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SLBEN reported negative net income in multiple years.
SLBEN had a negative operating cash flow in each of the past 5 years.
SLBEN.LS Yearly Net Income VS EBIT VS OCF VS FCFSLBEN.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

SLBEN has a Return On Assets of 6.02%. This is in the better half of the industry: SLBEN outperforms 77.55% of its industry peers.
SLBEN's Return On Equity of 30.59% is amongst the best of the industry. SLBEN outperforms 87.76% of its industry peers.
With an excellent Return On Invested Capital value of 11.88%, SLBEN belongs to the best of the industry, outperforming 89.80% of the companies in the same industry.
Industry RankSector Rank
ROA 6.02%
ROE 30.59%
ROIC 11.88%
ROA(3y)0.34%
ROA(5y)-1.77%
ROE(3y)-1.66%
ROE(5y)-9.84%
ROIC(3y)N/A
ROIC(5y)N/A
SLBEN.LS Yearly ROA, ROE, ROICSLBEN.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800 1K

1.3 Margins

The Profit Margin of SLBEN (18.66%) is better than 93.88% of its industry peers.
In the last couple of years the Profit Margin of SLBEN has declined.
Looking at the Operating Margin, with a value of 26.95%, SLBEN belongs to the top of the industry, outperforming 95.92% of the companies in the same industry.
In the last couple of years the Operating Margin of SLBEN has declined.
SLBEN's Gross Margin of 53.73% is in line compared to the rest of the industry. SLBEN outperforms 48.98% of its industry peers.
SLBEN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.95%
PM (TTM) 18.66%
GM 53.73%
OM growth 3YN/A
OM growth 5Y-11.5%
PM growth 3YN/A
PM growth 5Y-12.9%
GM growth 3Y3.32%
GM growth 5Y6.61%
SLBEN.LS Yearly Profit, Operating, Gross MarginsSLBEN.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SLBEN is creating value.
The number of shares outstanding for SLBEN remains at a similar level compared to 1 year ago.
The number of shares outstanding for SLBEN remains at a similar level compared to 5 years ago.
The debt/assets ratio for SLBEN has been reduced compared to a year ago.
SLBEN.LS Yearly Shares OutstandingSLBEN.LS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
SLBEN.LS Yearly Total Debt VS Total AssetsSLBEN.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

SLBEN has an Altman-Z score of 0.53. This is a bad value and indicates that SLBEN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SLBEN (0.53) is worse than 63.27% of its industry peers.
SLBEN has a Debt/Equity ratio of 1.23. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.23, SLBEN is doing worse than 65.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z 0.53
ROIC/WACC1.8
WACC6.59%
SLBEN.LS Yearly LT Debt VS Equity VS FCFSLBEN.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

SLBEN has a Current Ratio of 0.48. This is a bad value and indicates that SLBEN is not financially healthy enough and could expect problems in meeting its short term obligations.
SLBEN has a Current ratio of 0.48. This is amonst the worse of the industry: SLBEN underperforms 85.71% of its industry peers.
A Quick Ratio of 0.48 indicates that SLBEN may have some problems paying its short term obligations.
SLBEN's Quick ratio of 0.48 is on the low side compared to the rest of the industry. SLBEN is outperformed by 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.48
SLBEN.LS Yearly Current Assets VS Current LiabilitesSLBEN.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1

3. Growth

3.1 Past

The earnings per share for SLBEN have decreased strongly by -844.27% in the last year.
SLBEN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.75% yearly.
Looking at the last year, SLBEN shows a decrease in Revenue. The Revenue has decreased by -8.56% in the last year.
Measured over the past years, SLBEN shows a quite strong growth in Revenue. The Revenue has been growing by 10.50% on average per year.
EPS 1Y (TTM)-844.27%
EPS 3YN/A
EPS 5Y-3.75%
EPS Q2Q%-381.43%
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y10.84%
Revenue growth 5Y10.5%
Sales Q2Q%-13.8%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLBEN.LS Yearly Revenue VS EstimatesSLBEN.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLBEN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLBEN.LS Price Earnings VS Forward Price EarningsSLBEN.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLBEN.LS Per share dataSLBEN.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SLBEN!.
Industry RankSector Rank
Dividend Yield 0%

SPORT LISBOA E BENFICA-FUT S

ELI:SLBEN (12/15/2025, 7:00:00 PM)

6.24

-0.02 (-0.32%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners19.7%
Ins Owner ChangeN/A
Market Cap143.52M
Revenue(TTM)179.04M
Net Income(TTM)35.59M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.75
P/FCF N/A
P/OCF N/A
P/B 1.23
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-6.85
FCFYN/A
OCF(TTM)-2.52
OCFYN/A
SpS8.29
BVpS5.06
TBVpS-2.77
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 6.02%
ROE 30.59%
ROCE 15.04%
ROIC 11.88%
ROICexc 12.11%
ROICexgc 26.13%
OM 26.95%
PM (TTM) 18.66%
GM 53.73%
FCFM N/A
ROA(3y)0.34%
ROA(5y)-1.77%
ROE(3y)-1.66%
ROE(5y)-9.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y3.6%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.68%
OM growth 3YN/A
OM growth 5Y-11.5%
PM growth 3YN/A
PM growth 5Y-12.9%
GM growth 3Y3.32%
GM growth 5Y6.61%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 52.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.48
Altman-Z 0.53
F-Score4
WACC6.59%
ROIC/WACC1.8
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)45.58%
Cap/Sales(5y)48.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-844.27%
EPS 3YN/A
EPS 5Y-3.75%
EPS Q2Q%-381.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y10.84%
Revenue growth 5Y10.5%
Sales Q2Q%-13.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y965.99%
EBIT growth 3YN/A
EBIT growth 5Y-2.21%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0%
OCF growth 3YN/A
OCF growth 5YN/A

SPORT LISBOA E BENFICA-FUT S / SLBEN.LS FAQ

What is the ChartMill fundamental rating of SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SLBEN.LS.


What is the valuation status for SLBEN stock?

ChartMill assigns a valuation rating of 0 / 10 to SPORT LISBOA E BENFICA-FUT S (SLBEN.LS). This can be considered as Overvalued.


Can you provide the profitability details for SPORT LISBOA E BENFICA-FUT S?

SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) has a profitability rating of 5 / 10.


What is the financial health of SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) stock?

The financial health rating of SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) is 1 / 10.